A rapid spectrophotometric screening assay for paroxysmal nocturnal hemoglobinuria.
A rapid spectrophotometric screening assay for paroxysmal nocturnal hemoglobinuria.
复制标题
阵发性睡眠性血红蛋白尿的快速分光光度筛查测定。
DOI:
10.1159/000057638
复制
发表时间:
2002
影响因子:
2.4
通讯作者:
Brodsky,RobertA
中科院分区:
文献类型:
--
作者:
Mukhina,GalinaL;Buckley,Thomas;Brodsky,RobertA
Paroxysmal nocturnalhemoglobinuria (PNH) is a clonal hematopoietic stem cell disorder that leads to a complement-mediated hemolytic anemia and a propensity to thrombosis [1]. The genetic hallmark of PNH stem cells and their progeny is a somatic mutation in the x-linked gene, PIGA [2]. As a result, the cells are unable to synthesize glycosylphosphatidylinositol (GPI) anchors, which are used to tether a wide array of proteins to the plasma membrane. Consequently, many GPI-anchored proteins, including the complement-regulatory proteins CD59 and CD55, are deficient on PNH blood cells.In developed countries, traditional screening assays for PNH, such as the Ham test and sucrose hemolysis test, have been replaced by more sensitive and specific flow cytometric assays that utilize fluorescently labeled monoclonal antibodies to detect a deficiency of GPI-anchored proteins [3, 4]. We recently described an improved method to detect PNH, based on our discovery that GPI-anchored proteins serve as receptors for aerolysin [5], a bacterial toxin capable of lysing cells by forming membrane channels. Because they lack GPI-anchored proteins, PNH cells do not bind aerolysin and they are uniquely resistant to the toxin [6]. As a result, aerolysin and a fluorescently labeled inactive proaerolysin variant (FLAER) can be used in flow cytometric assays to detect PNH cells with greater sensitivity and specificity than individual monoclonal antibodies [7]. Although flow cytometry with FLAER or with monoclonal antibodies has become the standard for PNH detection in the developed world, it requires expensive equipment and significant technical expertise that is not widely available, especially in developing countries where PNH is more common. We now characterize a rapid and inexpensive screening assay for PNH that requires only a plate reader and aerolysin.